The results of Kaplan–Meier survival analysis also indicated that patients with low NIT1 expression levels had a poor prognosis in 160 CRC patients from a public clinical microarray database of GSE24551 (Fig. 1f). This evidence concerns the gene NIT1 and colorectal carcinoma.